# The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department

> **NCT06823154** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **The Hospital for Sick Children** · enrollment: 500 (estimated)

## Conditions studied

- Allergy Amoxicillin
- Beta-lactam Allergy Labels

## Interventions

- **DRUG:** Amoxicillin
- **OTHER:** Study questionnaire

## Key facts

- **NCT ID:** NCT06823154
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-27
- **Primary completion:** 2026-02-17
- **Final completion:** 2026-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06823154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06823154, "The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department". Retrieved via AI Analytics 2026-08-16 from https://api.ai-analytics.org/clinical/NCT06823154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*